Also, significantly elevated BIM levels (p<0.01) were detectable in the apoptotic tumor centers versus proliferating tumor margins in HNSCC patients (n=31), underlining BIM's clinical relevance. The gene discussed is BCL2L11; the disease is head and neck squamous cell carcinoma.